Stefano Scalera

13PUBLICATIONS
135CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer cell biologyEpigenetics (incl. genome methylation and epigenomics)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jul 15, 2026
Intratumoral Immune Heterogeneity Drives Divergent Outcomes to PD-(L)1 Blockade in Lung Cancer.

|Jul 14, 2026
Clinical Significance of EGFR Amplification in Patients with EGFR-Mutated Metastatic Non-Small Cell Lung Cancer Receiving First-line Osimertinib.

|May 25, 2026
Gene mutant dosage is associated with prognosis and metastatic tropism in 60,000 clinical cancer samples.

|May 18, 2026
Clinical Outcomes and Predictors of Response to PD-(L)1 Blockade in Patients with NSCLC without Actionable Genomic Alterations Who Never Used Tobacco.

|Mar 24, 2026
AATF supports proliferation of glioblastoma cells by sustaining mitochondrial respiration through an NRF-1-dependent mechanism.

Cristina Sorino, Stefano Di Giovenale, Italia Falcone

|Jan 28, 2026
Aberrant Activation of the Hedgehog Pathway in Cutaneous Melanoma: Therapeutic Potential of Pharmacological Inhibitors.

Federica Papaccio, Daniela Kovacs, Ramona Marrapodi

Pageof 3

Frequent Collaborators

5 joint publications

Marcello Maugeri-Saccà

5 joint publications

Biagio Ricciuti

4 joint publications

Laura Cipriani

4 joint publications

Federico Cappuzzo